119 related articles for article (PubMed ID: 8723585)
21. Epoetin alfa. A bloodless approach for the treatment of perioperative anemia.
Faris PM; Ritter MA
Clin Orthop Relat Res; 1998 Dec; (357):60-7. PubMed ID: 9917701
[TBL] [Abstract][Full Text] [Related]
22. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.
Scott SN; Boeve TJ; McCulloch TM; Fitzpatrick KA; Karnell LH
Laryngoscope; 2002 Jul; 112(7 Pt 1):1221-9. PubMed ID: 12169903
[TBL] [Abstract][Full Text] [Related]
23. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery].
Bisbe E; Sáez M; Nomen N; Castillo J; Santiveri X; Mestre C; Cano X
Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):395-400. PubMed ID: 14601367
[TBL] [Abstract][Full Text] [Related]
24. Preoperative epoetin alfa vs autologous blood donation in primary total knee arthroplasty.
Deutsch A; Spaulding J; Marcus RE
J Arthroplasty; 2006 Aug; 21(5):628-35. PubMed ID: 16877146
[TBL] [Abstract][Full Text] [Related]
25. Preoperative methods to improve erythropoiesis.
Bacuzzi A; Dionigi G; Piffaretti G; Tozzi M; Del Romano M; Guzzetti L; Paracchini F; Villa F; Cuffari S
Transplant Proc; 2011; 43(1):324-6. PubMed ID: 21335214
[TBL] [Abstract][Full Text] [Related]
26. Preoperative epoetin alfa in colorectal surgery: a randomized, controlled study.
Christodoulakis M; Tsiftsis DD;
Ann Surg Oncol; 2005 Sep; 12(9):718-25. PubMed ID: 16052276
[TBL] [Abstract][Full Text] [Related]
27. Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin.
Price TH; Goodnough LT; Vogler WR; Sacher RA; Hellman RM; Johnston MF; Bolgiano DC; Abels RI
Am J Med; 1996 Aug; 101(2A):22S-27S. PubMed ID: 8928704
[TBL] [Abstract][Full Text] [Related]
28. Epoetin alfa and high-dose chemotherapy.
Henry DH
Semin Oncol; 1998 Jun; 25(3 Suppl 7):54-7. PubMed ID: 9671332
[TBL] [Abstract][Full Text] [Related]
29. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy.
Chun TY; Martin S; Lepor H
Urology; 1997 Nov; 50(5):727-32. PubMed ID: 9372883
[TBL] [Abstract][Full Text] [Related]
30. Epoetin alfa in low hematocrit patients to facilitate autologous blood donation in total hip replacement: a randomized, double-blind, placebo-controlled, dose-ranging study.
Mercuriali F; Inghilleri G; Biffi E; Colotti MT; Vinci A; Oriani G
Acta Haematol; 1998; 100(2):69-76. PubMed ID: 9792935
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss.
Arroliga AC; Guntupalli KK; Beaver JS; Langholff W; Marino K; Kelly K
Crit Care Med; 2009 Apr; 37(4):1299-307. PubMed ID: 19242343
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
[TBL] [Abstract][Full Text] [Related]
33. Patients previously transfused or treated with epoetin alfa at low baseline hemoglobin are at higher risk for subsequent transfusion: an integrated analysis of the Canadian experience.
Quirt I; Kovacs M; Couture F; Turner AR; Noble M; Burkes R; Dolan S; Plante RK; Lau CY; Chang J
Oncologist; 2006 Jan; 11(1):73-82. PubMed ID: 16401716
[TBL] [Abstract][Full Text] [Related]
34. The impact of epoetin alfa on quality of life during cancer chemotherapy: a fresh look at an old problem.
Glaspy J
Semin Hematol; 1997 Jul; 34(3 Suppl 2):20-6. PubMed ID: 9253780
[TBL] [Abstract][Full Text] [Related]
35. A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer.
Ariganello O; Mancuso A; Di Molfetta M; Diana F; Beccaglia P; Cortesi E; De Marinis F
Lung Cancer; 2004 Oct; 46(1):119-24. PubMed ID: 15364140
[TBL] [Abstract][Full Text] [Related]
36. Autologous versus allogeneic transfusion: patients' perceptions and experiences.
Graham ID; Fergusson D; Dokainish H; Biggs J; McAuley L; Laupacis A
CMAJ; 1999 Apr; 160(7):989-95. PubMed ID: 10207337
[TBL] [Abstract][Full Text] [Related]
37. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs.
Goodnough LT; Brittenham GM
J Lab Clin Med; 1990 Jan; 115(1):28-35. PubMed ID: 2299254
[TBL] [Abstract][Full Text] [Related]
38. Darbepoetin alfa: new indication/new dosage. No proven advantage in chemotherapy-induced anaemia.
Prescrire Int; 2005 Oct; 14(79):174-6. PubMed ID: 16285072
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview.
Bieber E
J Reprod Med; 2001 May; 46(5 Suppl):521-30. PubMed ID: 11396386
[TBL] [Abstract][Full Text] [Related]
40. Management of chemotherapy-induced anemia in solid tumors.
Thatcher N
Semin Oncol; 1998 Jun; 25(3 Suppl 7):23-6. PubMed ID: 9671326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]